TB-500 vs Thymosin Beta-4: Sequence and Research Differences
TB-500 and full-length thymosin beta-4 are different peptide materials. Here, TB-500 refers specifically to Ac-LKKTETQ, a seven-residue acetylated fragment. Full-length thymosin beta-4 contains 43 amino-acid residues. A shared sequence region does not make the two materials interchangeable.
For the fragment offered by Vertex Labs, review the TB-500 5 mg and 10 mg product specifications and the documentation associated with the selected batch.
TB-500 vs thymosin beta-4: the identity difference
| Feature | TB-500 fragment discussed here | Full-length thymosin beta-4 |
|---|---|---|
| Length | 7 amino-acid residues | 43 amino-acid residues |
| Sequence relationship | Ac-LKKTETQ; acetylated fragment corresponding to residues 17–23 of the mature parent peptide | Complete peptide, including the LKKTETQ region |
| Meaning of “Ac” | N-terminal acetyl group on the isolated fragment | The parent peptide has its own N-terminus; the internal LKKTETQ region is not a separate acetylated fragment |
| Literature review | Check that the experiment actually used this fragment | Check that the experiment used the complete peptide |
The fragment identification is documented in Esposito and colleagues’ 2012 analytical study. The 43-residue structure and acetylated N-terminus of thymosin beta-4 are described in Low and Goldstein’s chemical characterization study.
Why the distinction matters when reading research
Begin with the methods section rather than the shorthand name in a headline. Record the sequence, terminal modifications and source of the material. If a paper uses full-length thymosin beta-4, cite its findings as findings about that material. Do not present them as direct evidence for the isolated TB-500 fragment.
The same discipline applies to fragments and metabolites. A result for a breakdown product should remain attributed to that breakdown product. For an explanation of the analytical and metabolism literature, see our TB-500 research guide.
How to check a product listing and COA
For laboratory procurement, treat the product name as the starting point for a documentation check:
- Identify the intended material. Look for an explicit sequence and terminal modifications, not just an abbreviated product name.
- Match the lot. Compare the selected product and vial size with the lot identifier on the supplied material and report.
- Read the test scope. Check which identity or quality measurements the report actually includes. Do not infer an unreported test from a general quality statement.
- Resolve missing information. If the documentation does not establish something required by your experiment, request clarification before proceeding.
Use the batch COA directory and testing standards page together with the individual product listing. For more detail on analytical approaches, see peptide sequence characterization methods.
Frequently asked questions
Does “TB-500” mean full-length thymosin beta-4 on this site?
This comparison uses TB-500 for the Ac-LKKTETQ fragment described in the linked product specifications. Confirm the stated identity and batch documentation when selecting research material.
Can a full-length thymosin beta-4 study validate a TB-500 batch?
No. A publication and a batch report serve different purposes. The publication describes its own experimental material; the batch documentation concerns the identified sample and tests reported.
Where should I start when comparing TB-500 with BPC-157?
Use the separate TB-500 vs BPC-157 guide to compare their identities and documentation requirements.
Research use only. Vertex Labs materials are intended for laboratory research, not human or animal use. This comparison does not establish therapeutic equivalence or provide administration guidance.